To reliably model drug delivery in AD, we generated iBECs from previously published APOE3 and APOE4-carrying human iPSCs (N = 3), including one isogenic pair in which both APOE4 alleles had been converted to APOE3 using CRISPR-Cas9 37-39. The gene discussed is APOE; the disease is Alzheimer disease.